Marker Therapeutics is advancing a unique multi antigen recognizing (MAR)-T cell therapy platform designed to target multiple tumor-associated antigens simultaneously, an approach that has shown ...
Bayer said on Tuesday it was preparing market launches this year of two new drugs that could each have annual peak sales of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback